120 related articles for article (PubMed ID: 38902449)
1. Targeting NRP1 axis as a strategy for treating energy metabolism impairment induced by SARS-CoV-2 spike.
Zhang L; Hu W; Li J; Li Y; Liu F; Xiao W; Jiang N; Xiao Z; Han L; Zhou W
Sci China Life Sci; 2024 Jun; ():. PubMed ID: 38902449
[No Abstract] [Full Text] [Related]
2. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
Zaheer M; Ali N; Javed H; Munir R; Jamil N
J Infect Public Health; 2023 Oct; 16(10):1544-1555. PubMed ID: 37566991
[TBL] [Abstract][Full Text] [Related]
3. Biophysical investigation of interactions between SARS-CoV-2 spike protein and neuropilin-1.
Hou D; Cao W; Kim S; Cui X; Ziarnik M; Im W; Zhang XF
Protein Sci; 2023 Oct; 32(10):e4773. PubMed ID: 37656811
[TBL] [Abstract][Full Text] [Related]
4. Discovery of dual S-RBD/NRP1-targeting peptides: structure-based virtual screening, synthesis, biological evaluation, and molecular dynamics simulation studies.
Hu C; Guo T; Zou Y; Gao J; Gao Y; Niu M; Xia Y; Shen X; Li J
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2212327. PubMed ID: 37194732
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Analysis of NRP1 in Malignancies Provide Therapeutic Implication for Treating Cancer Patients Infected with SARS-CoV-2.
Chen S; Zhang L; Song Y; Xie K; Wang Y; Liang Y
Biochem Genet; 2023 Nov; ():. PubMed ID: 37938510
[TBL] [Abstract][Full Text] [Related]
6. Mutating novel interaction sites in NRP1 reduces SARS-CoV-2 spike protein internalization.
Pal D; De K; Yates TB; Kolape J; Muchero W
iScience; 2023 Apr; 26(4):106274. PubMed ID: 36910328
[TBL] [Abstract][Full Text] [Related]
7. Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein Domains S1 and S2.
Li ZL; Buck M
bioRxiv; 2021 Jan; ():. PubMed ID: 33442700
[TBL] [Abstract][Full Text] [Related]
8. Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1.
Kolarič A; Jukič M; Bren U
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215277
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2.
Li ZL; Buck M
Biophys J; 2021 Jul; 120(14):2828-2837. PubMed ID: 34087218
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity.
Saiz ML; DeDiego ML; López-García D; Corte-Iglesias V; Baragaño Raneros A; Astola I; Asensi V; López-Larrea C; Suarez-Alvarez B
Clin Epigenetics; 2021 Oct; 13(1):187. PubMed ID: 34635175
[TBL] [Abstract][Full Text] [Related]
11. Emerging SARS-CoV-2 variants of concern potentially expand host range to chickens: insights from AXL, NRP1 and ACE2 receptors.
Lei M; Ma Y; Chen H; Huang P; Sun J; Wang X; Sun Q; Hu Y; Shi J
Virol J; 2023 Aug; 20(1):196. PubMed ID: 37644471
[TBL] [Abstract][Full Text] [Related]
12. Discovery of natural products to block SARS-CoV-2 S-protein interaction with Neuropilin-1 receptor: A molecular dynamics simulation approach.
Alshawaf E; Hammad MM; Marafie SK; Ali H; Al-Mulla F; Abubaker J; Mohammad A
Microb Pathog; 2022 Sep; 170():105701. PubMed ID: 35963279
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists.
Klaewkla M; Charoenwongpaiboon T; Mahalapbutr P
J Mol Liq; 2021 Aug; 335():116537. PubMed ID: 34031621
[TBL] [Abstract][Full Text] [Related]
14. Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection.
Mei S; Zou Y; Jiang S; Xue L; Wang Y; Jing H; Yang P; Niu MM; Li J; Yuan K; Zhang Y
Eur J Med Chem; 2024 Jan; 263():115908. PubMed ID: 37981444
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy.
Huang Y; Wang Y; Xu D; Xiao L; Qin W; Liu B; Yuan X
Front Genet; 2022; 13():995736. PubMed ID: 36338984
[TBL] [Abstract][Full Text] [Related]
16. Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin.
Jobe A; Vijayan R
Heliyon; 2021 Oct; 7(10):e08251. PubMed ID: 34722943
[TBL] [Abstract][Full Text] [Related]
17. Natural Product Cordycepin (CD) Inhibition for NRP1/CD304 Expression and Possibly SARS-CoV-2 Susceptibility Prevention on Cancers.
Li T; Luo N; Fu J; Du J; Liu Z; Tan Q; Zheng M; He J; Cheng J; Li D; Fu J
Microorganisms; 2023 Dec; 11(12):. PubMed ID: 38138098
[TBL] [Abstract][Full Text] [Related]
18.
Hu S; Hu Z; Qin J; Lin C; Jiang X
Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
[TBL] [Abstract][Full Text] [Related]
19. Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis.
Baindara P; Roy D; Mandal SM; Schrum AG
Infect Dis Rep; 2022 Mar; 14(2):243-249. PubMed ID: 35447881
[TBL] [Abstract][Full Text] [Related]
20. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein.
Fernandez RA; Quimque MT; Notarte KI; Manzano JA; Pilapil DY; de Leon VN; San Jose JJ; Villalobos O; Muralidharan NH; Gromiha MM; Brogi S; Macabeo APG
J Biomol Struct Dyn; 2022; 40(22):12209-12220. PubMed ID: 34463219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
